메뉴 건너뛰기




Volumn 82, Issue 3, 2012, Pages 457-464

PLGA microspheres encapsulating siRNA anti-TNFalpha: Efficient RNAi-mediated treatment of arthritic joints

Author keywords

Experimental arthritis; PLGA microspheres; Poly(dl lactic glycolic acid) (PLGA); Small interfering RNA (siRNA); Tumor necrosis factor (TNF)

Indexed keywords

MICROSPHERE; POLYGLACTIN; RESOMER; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

EID: 84870508971     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.07.021     Document Type: Article
Times cited : (39)

References (35)
  • 1
    • 78349284844 scopus 로고    scopus 로고
    • Aspects of TNF inhibitor therapy in rheumatoid arthritis
    • J. Nam, and P. Emery Aspects of TNF inhibitor therapy in rheumatoid arthritis Mod Rheumatol. 20 4 2010 325 330
    • (2010) Mod Rheumatol. , vol.20 , Issue.4 , pp. 325-330
    • Nam, J.1    Emery, P.2
  • 2
    • 34249720998 scopus 로고    scopus 로고
    • Cytokines in the pathogenesis of rheumatoid arthritis
    • I.B. McInnes, and G. Schett Cytokines in the pathogenesis of rheumatoid arthritis Nat. Rev. Immunol. 7 6 2007 429 442
    • (2007) Nat. Rev. Immunol. , vol.7 , Issue.6 , pp. 429-442
    • McInnes, I.B.1    Schett, G.2
  • 3
    • 33646696885 scopus 로고    scopus 로고
    • Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
    • T. Bongartz, A.J. Sutton, M.J. Sweeting, I. Buchan, E.L. Matteson, and V. Montori Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials JAMA 17 295 19 2006 2275 2285
    • (2006) JAMA 17 , vol.295 , Issue.19 , pp. 2275-2285
    • Bongartz, T.1    Sutton, A.J.2    Sweeting, M.J.3    Buchan, I.4    Matteson, E.L.5    Montori, V.6
  • 4
    • 40549146541 scopus 로고    scopus 로고
    • Tumor necrosis factor inhibition: A part of the solution or a part of the problem of heart failure in rheumatoid arthritis?
    • S.E. Gabriel Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis? Arthritis Rheum. 58 3 2008 637 640
    • (2008) Arthritis Rheum. , vol.58 , Issue.3 , pp. 637-640
    • Gabriel, S.E.1
  • 5
    • 17244378648 scopus 로고    scopus 로고
    • Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis
    • R.M. Schiffelers, J. Xu, G. Storm, M.C. Woodle, and P.V. Scaria Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis Arthritis Rheum. 52 4 2005 1314 1318
    • (2005) Arthritis Rheum. , vol.52 , Issue.4 , pp. 1314-1318
    • Schiffelers, R.M.1    Xu, J.2    Storm, G.3    Woodle, M.C.4    Scaria, P.V.5
  • 7
    • 58149215702 scopus 로고    scopus 로고
    • Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model
    • K.A. Howard, S.R. Paludan, M.A. Behlke, F. Besenbacher, B. Deleuran, and J. Kjems Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model Mol. Ther. 17 1 2009 162 168
    • (2009) Mol. Ther. , vol.17 , Issue.1 , pp. 162-168
    • Howard, K.A.1    Paludan, S.R.2    Behlke, M.A.3    Besenbacher, F.4    Deleuran, B.5    Kjems, J.6
  • 8
    • 33745014998 scopus 로고    scopus 로고
    • Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis
    • M. Khoury, P. Louis-Plence, V. Escriou, D. Noel, C. Largeau, C. Cantos, D. Scherman, C. Jorgensen, and F. Apparailly Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis Arthritis Rheum. 54 6 2006 1867 1877
    • (2006) Arthritis Rheum. , vol.54 , Issue.6 , pp. 1867-1877
    • Khoury, M.1    Louis-Plence, P.2    Escriou, V.3    Noel, D.4    Largeau, C.5    Cantos, C.6    Scherman, D.7    Jorgensen, C.8    Apparailly, F.9
  • 11
    • 0343247711 scopus 로고    scopus 로고
    • Biodegradation and biocompatibility of PLA and PLGA microspheres
    • J.M. Anderson, and M.S. Shive Biodegradation and biocompatibility of PLA and PLGA microspheres Adv. Drug Deliv. Rev. 28 1 1997 5 24
    • (1997) Adv. Drug Deliv. Rev. , vol.28 , Issue.1 , pp. 5-24
    • Anderson, J.M.1    Shive, M.S.2
  • 12
    • 0036278466 scopus 로고    scopus 로고
    • Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes
    • G. De Rosa, F. Quaglia, M.I. La Rotonda, M. Appel, H. Alphandary, and E. Fattal Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes J. Pharm. Sci. 91 3 2002 790 799
    • (2002) J. Pharm. Sci. , vol.91 , Issue.3 , pp. 790-799
    • De Rosa, G.1    Quaglia, F.2    La Rotonda, M.I.3    Appel, M.4    Alphandary, H.5    Fattal, E.6
  • 13
    • 0037453175 scopus 로고    scopus 로고
    • A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes
    • G. De Rosa, A. Bochot, F. Quaglia, M. Besnard, and E. Fattal A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes Int. J. Pharm. 254 1 2003 89 93
    • (2003) Int. J. Pharm. , vol.254 , Issue.1 , pp. 89-93
    • De Rosa, G.1    Bochot, A.2    Quaglia, F.3    Besnard, M.4    Fattal, E.5
  • 14
    • 0037503753 scopus 로고    scopus 로고
    • Long-term release and improved intracellular penetration of oligonucleotide-polyethylenimine complexes entrapped in biodegradable microspheres
    • G. De Rosa, F. Quaglia, A. Bochot, F. Ungaro, and E. Fattal Long-term release and improved intracellular penetration of oligonucleotide- polyethylenimine complexes entrapped in biodegradable microspheres Biomacromolecules 4 3 2003 529 536
    • (2003) Biomacromolecules , vol.4 , Issue.3 , pp. 529-536
    • De Rosa, G.1    Quaglia, F.2    Bochot, A.3    Ungaro, F.4    Fattal, E.5
  • 15
    • 21044440000 scopus 로고    scopus 로고
    • Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres
    • G. De Rosa, M.C. Maiuri, F. Ungaro, D. De Stefano, F. Quaglia, M.I. La Rotonda, and R. Carnuccio Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres J. Gene. Med. 7 6 2005 771 781
    • (2005) J. Gene. Med. , vol.7 , Issue.6 , pp. 771-781
    • De Rosa, G.1    Maiuri, M.C.2    Ungaro, F.3    De Stefano, D.4    Quaglia, F.5    La Rotonda, M.I.6    Carnuccio, R.7
  • 16
    • 39649104546 scopus 로고    scopus 로고
    • Ant-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice
    • N. Murata, Y. Takashima, K. Toyoshima, M. Yamamoto, and H. Okada Ant-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice J. Controlled Release 126 2008 246 254
    • (2008) J. Controlled Release , vol.126 , pp. 246-254
    • Murata, N.1    Takashima, Y.2    Toyoshima, K.3    Yamamoto, M.4    Okada, H.5
  • 17
    • 0036182057 scopus 로고    scopus 로고
    • Size-dependency of dl-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium
    • E. Horisawa, K. Kubota, I. Tuboi, K. Sato, H. Yamamoto, H. Takeuchi, and Y. Kawashima Size-dependency of dl-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium Pharm. Res. 19 2 2002 132 139
    • (2002) Pharm. Res. , vol.19 , Issue.2 , pp. 132-139
    • Horisawa, E.1    Kubota, K.2    Tuboi, I.3    Sato, K.4    Yamamoto, H.5    Takeuchi, H.6    Kawashima, Y.7
  • 18
    • 0347264779 scopus 로고    scopus 로고
    • Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: Application to interleukin 10 therapy in experimental arthritis
    • N. Perez, P. Plence, V. Millet, D. Greuet, C. Minot, D. Noel, O. Danos, C. Jorgensen, and F. Apparailly Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis Hum. Gene. Ther. 13 18 2002 2161 2172
    • (2002) Hum. Gene. Ther. , vol.13 , Issue.18 , pp. 2161-2172
    • Perez, N.1    Plence, P.2    Millet, V.3    Greuet, D.4    Minot, C.5    Noel, D.6    Danos, O.7    Jorgensen, C.8    Apparailly, F.9
  • 20
    • 33847381116 scopus 로고    scopus 로고
    • The fundamental basis of inflammatory bowel disease
    • W. Strober, I. Fuss, and P. Mannon The fundamental basis of inflammatory bowel disease J. Clin. Invest. 117 3 2007 514 521
    • (2007) J. Clin. Invest. , vol.117 , Issue.3 , pp. 514-521
    • Strober, W.1    Fuss, I.2    Mannon, P.3
  • 21
    • 34249929951 scopus 로고    scopus 로고
    • Biological therapies in inflammatory bowel disease: Top-down or bottom-up?
    • B. Oldenburg, and D. Hommes Biological therapies in inflammatory bowel disease: top-down or bottom-up? Curr. Opin. Gastroenterol. 23 4 2007 395 399
    • (2007) Curr. Opin. Gastroenterol. , vol.23 , Issue.4 , pp. 395-399
    • Oldenburg, B.1    Hommes, D.2
  • 22
    • 0033125226 scopus 로고    scopus 로고
    • Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety
    • W.J. Sandborn, and S.B. Hanauer Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety Inflamm. Bowel. Dis. 5 2 1999 119 133
    • (1999) Inflamm. Bowel. Dis. , vol.5 , Issue.2 , pp. 119-133
    • Sandborn, W.J.1    Hanauer, S.B.2
  • 23
    • 0037630207 scopus 로고    scopus 로고
    • New biological therapies in inflammatory bowel disease
    • S.J. van Deventer New biological therapies in inflammatory bowel disease Best Pract Res. Clin. Gastroenterol. 17 1 2003 119 130
    • (2003) Best Pract Res. Clin. Gastroenterol. , vol.17 , Issue.1 , pp. 119-130
    • Van Deventer, S.J.1
  • 25
    • 67651154470 scopus 로고    scopus 로고
    • Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    • F. Hoentjen, and A.A. van Bodegraven Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease World J. Gastroenterol. 15 17 2009 2067 2073
    • (2009) World J. Gastroenterol. , vol.15 , Issue.17 , pp. 2067-2073
    • Hoentjen, F.1    Van Bodegraven, A.A.2
  • 26
    • 0141552295 scopus 로고    scopus 로고
    • Gene silencing by systemic delivery of synthetic siRNAs in adult mice
    • D.R. Sorensen, M. Leirdal, and M. Sioud Gene silencing by systemic delivery of synthetic siRNAs in adult mice J. Mol. Biol. 327 4 2003 761 766
    • (2003) J. Mol. Biol. , vol.327 , Issue.4 , pp. 761-766
    • Sorensen, D.R.1    Leirdal, M.2    Sioud, M.3
  • 27
    • 73349104443 scopus 로고    scopus 로고
    • Tumor necrosis factor alpha-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis
    • A. Inoue, I. Matsumoto, Y. Tanaka, K. Iwanami, A. Kanamori, N. Ochiai, D. Goto, S. Ito, and T. Sumida Tumor necrosis factor alpha-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis Arthritis Res. Ther. 11 4 2009 R118
    • (2009) Arthritis Res. Ther. , vol.11 , Issue.4 , pp. 118
    • Inoue, A.1    Matsumoto, I.2    Tanaka, Y.3    Iwanami, K.4    Kanamori, A.5    Ochiai, N.6    Goto, D.7    Ito, S.8    Sumida, T.9
  • 28
    • 69549097534 scopus 로고    scopus 로고
    • Nano and microtechnologies for the delivery of oligonucleotides with gene silencing properties
    • G. De Rosa, and M.I. La Rotonda Nano and microtechnologies for the delivery of oligonucleotides with gene silencing properties Molecules 14 8 2009 2801 2823
    • (2009) Molecules , vol.14 , Issue.8 , pp. 2801-2823
    • De Rosa, G.1    La Rotonda, M.I.2
  • 30
    • 0036108432 scopus 로고    scopus 로고
    • Prolonged anti-inflammatory action of dl-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit
    • E. Horisawa, T. Hirota, S. Kawazoe, J. Yamada, H. Yamamoto, H. Takeuchi, and Y. Kawashima Prolonged anti-inflammatory action of dl-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit Pharm. Res. 19 2002 403 410
    • (2002) Pharm. Res. , vol.19 , pp. 403-410
    • Horisawa, E.1    Hirota, T.2    Kawazoe, S.3    Yamada, J.4    Yamamoto, H.5    Takeuchi, H.6    Kawashima, Y.7
  • 31
    • 78049431300 scopus 로고    scopus 로고
    • Intraarticular microparticles for drug delivery to the rat TMJ
    • P.M. Mountziaris, D.C. Sing, A.G. Mikos, and P.R. Kramer Intraarticular microparticles for drug delivery to the rat TMJ J. Dent. Res. 89 2010 1039 1044
    • (2010) J. Dent. Res. , vol.89 , pp. 1039-1044
    • Mountziaris, P.M.1    Sing, D.C.2    Mikos, A.G.3    Kramer, P.R.4
  • 32
    • 84870489351 scopus 로고    scopus 로고
    • Polymeric nano and microparticles for the delivery of antisense oligonucleotides and SiRNA
    • Nancy Smyth Templeton 3rd ed. Taylor & Francis Group, CRC Press
    • E. Fattal, and G. De Rosa Polymeric nano and microparticles for the delivery of antisense oligonucleotides and SiRNA Nancy Smyth Templeton Gene and Cell Therapy: Therapeutic Mechanisms and Strategies 3rd ed. 2008 Taylor & Francis Group, CRC Press 599 615
    • (2008) Gene and Cell Therapy: Therapeutic Mechanisms and Strategies , pp. 599-615
    • Fattal, E.1    De Rosa, G.2
  • 33
    • 55649089421 scopus 로고    scopus 로고
    • State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers
    • E. Fattal, and A. Bochot State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers Int. J. Pharm. 364 2 2008 237 248
    • (2008) Int. J. Pharm. , vol.364 , Issue.2 , pp. 237-248
    • Fattal, E.1    Bochot, A.2
  • 34
    • 78650697312 scopus 로고    scopus 로고
    • High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: Quality by design optimization and characterization
    • D. Cun, D.K. Jensen, M.J. Maltesen, M. Bunker, P. Whiteside, D. Scurr, C. Foged, and H.M. Nielsen High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization Eur. J. Pharm. Biopharm. 77 1 2011 26 35
    • (2011) Eur. J. Pharm. Biopharm. , vol.77 , Issue.1 , pp. 26-35
    • Cun, D.1    Jensen, D.K.2    Maltesen, M.J.3    Bunker, M.4    Whiteside, P.5    Scurr, D.6    Foged, C.7    Nielsen, H.M.8
  • 35
    • 79959915001 scopus 로고    scopus 로고
    • Controlled release of anti-inflammatory siRNA from biodegradable polymeric microparticles intended for intra-articular delivery to the temporomandibular joint
    • P.M. Mountziaris, D.C. Sing, S.A. Chew, S.N. Tzouanas, E.D. Lehman, F.K. Kasper, and A.G. Mikos Controlled release of anti-inflammatory siRNA from biodegradable polymeric microparticles intended for intra-articular delivery to the temporomandibular joint Pharm. Res. 28 6 2011 1370 1384
    • (2011) Pharm. Res. , vol.28 , Issue.6 , pp. 1370-1384
    • Mountziaris, P.M.1    Sing, D.C.2    Chew, S.A.3    Tzouanas, S.N.4    Lehman, E.D.5    Kasper, F.K.6    Mikos, A.G.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.